South Africa has suspended the rollout of the Oxford/AstraZeneca vaccine to healthcare staff after a study suggested it was not effective against mild illness caused by the variant discovered there.The country received its first one million doses of the vaccine at the end of January ahead of a planned rollout to frontline health workers from the middle of February.The plans have now been halted after preliminary research suggested the vaccine offers minimal protection against mild to moderate disease from the mutation.
India has worked with South Africa and other partners in the WTO to seek relaxation in the norms of the TRIPS agreement, Foreign Secretary Harsh Vardhan Shringla said on Friday and noted that this waiver will be an important step for enabling the rapid scaling up of manufacture and timely availability of affordable COVID-19 vaccines and essential medical products on a global basis. "India has also worked with South Africa and other partners in WTO to seek relaxation in norms of TRIPS agreement to ensure quick and affordable access to vaccines and medicines for developing countries during the COVID pandemic," said Foreign Secretary Shringla at UNSC high-level meeting.
Sam Simmonds has been named in a British and Irish Lions squad that is captained by Alun Wyn Jones, but Kyle Sinckler and Johnny Sexton are among several high-profile omissions.Simmonds, the Exeter number eight and current European player of the year, has been picked by Warren Gatland despite being consistently overlooked by England since winning the last of his seven caps in 2018.
Credit: PA - Press Association STUDIO Duration: 00:52Published
Under-40s in the UK will be offered an alternative coronavirus vaccine to the Oxford/AstraZeneca jab. The Joint Committee on Vaccination and Immunisation (JCVI) said there is an "extremely small risk" of people suffering blood clots after having the jab.
Report by Thomasl. Like us on Facebook at http://www.facebook.com/itn and follow us on Twitter at http://twitter.com/itn
Union External Affairs Minister, Dr S Jaishankar attended a virtual conversation, called 'Global Dialogue Series' on May 05. He said, "Our vaccine production situation was different from many other countries. On what basis Covishield was being made in India? It's Oxford-AstraZeneca vaccine, you can say it's British-designed product. It was made in India as the vaccine owner saw India as an efficient production venue. Along with that the ability and approval to make in India, came an obligation to supply it to a large part of the world. So, people have to understand, it was not that vaccine production started in India, it was invented by an Indian, owned by an Indian, produced by an Indian." He further said, "It was a truly international collaboration. When there is an international collaboration, if somebody gave you a vaccine to make in India, then you have to do your part, otherwise, it doesn't work. It also came with support from the Covax initiative. So, there was an obligation to support the Covax initiative to give vaccines at a low cost to a number of nations."
Maharashtra Congress Chief chief Nana Patole has responded to SII chief Adar Poonawalla’s allegation that he is being threatened. Addressing the media, Patole said that Congress is worried over Poonawalla’s allegations and said that the Congress would take the responsibility of ensuring his security. He further urged Poonawalla to name those politicians who had threatened him over vaccine production. Poonawalla, who flew to London last week, is chief executive officer of the Serum Institute, which is the local maker of the coronavirus vaccine developed by Oxford University and pharmaceuticals company AstraZeneca. Watch the full video for all the details.
Credit: HT Digital Content Duration: 02:05Published